Clinical Trials

Polyneuropathy

Displaying 2 studies

A Non-interventional Cohort Safety Study Of Patients With HATTR-PN Rochester, MN

The purpose of this study with the Health Authorities from the United States (US), Canada and Europe, is to collect long-term safety information (including any potential side effects) for the drug TEGSEDI in patients with hATTR-PN under real-world conditions.
A Study To Evaluate The Efficacy And Safety Of AKCEA-TTR-LRx In Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Scottsdale/Phoenix, AZ

The purpose of this study is to evaluate the effectiveness and safety of AKCEA-TTR-LRx after administration for 65 weeks to patients with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN), as compared to the NEURO-TTR trial (NCT01737398).

For more information, please visit http://www.neuro-ttransform.com/.